pawapuri theme-beyond the horizon - bcf india cancer foundation-india breast cancer foundation -...

& Director, Mahavir Cancer Sansthan, Phulwarisharif, Patna - 801 505

Ph. : 0612 - 2250127, 2253956, Fax : 0612 - 2253957Email : [email protected] / [email protected]

Mobile : 94310 21001

OFFICE ADDRESSDr. Jitendra Kumar Singh

National SecretaryBreast Cancer Foundation - India

Theme-Beyond the Horizon

NATIONAL SEMINAR OF NATIONAL SEMINAR OF NATIONAL SEMINAR OF

th th04 & 05 August 2012

Patna AttractionsRajgir

Pawapuri

Bodhgaya

Golghar

Rajgir (Rajgrahi) is the famous pilgrimage centre for Jains, this is also

known as Panch Pahadi. Rajgir is famous as Jain Teerth from ancient

times. Twentieth Teerthankar Bhagwan Muni Suvratnath's four

Kalyanka - Garbha, Janma, Tapa and Gyan (Juan) were celebrated at this

sacred place. This place was capital of King Jarasandha (Contemporary

to Lord Krishna & Bhagwan Neminath) and capital of the emperor of

Magadha King Shrenik (Bimbsar). King Shrenik was the principal disciple

of Bhagwan Mahaveer. Rajgrahi had the great strategic importance also

at that time.

Pava is a holy site for Jains located in the Nalanda district and 101 kilometers from Patna. An exquisite

marble temple in the middle of a lotus pond, the Jalmandir, stands magnificently on a rectangular

island. Another Jain temple, called Samosharan is located here, where the Lord Mahavira delivered

his last teaching.

Bodh Gaya is a religious site and place of pilgrimage

associated with the Mahabodhi Temple Complex in Gaya

district and it is 125 Kms away from Patna. It is famous for

being the place where Gautama Buddha is said to have

obtained Enlightenment (Bodhimandala). In 2002,

Mahabodhi Temple, located in Bodh Gaya, became a

UNESCO World Heritage Site.

Golghar is a granary built by Captain John Garstin, in 1786.

One interesting fact about the Golghar is that never in its

existence has it been filled to its maximum capacity and there

are no plans in future as well.

Breast Cancer Foundation-India

Dear Colleague,

Thanking you & looking forward to see you at Patna

Breast Cancer is a complicated disease and although enormous progress

has been made over the last decade, many challenges lie ahead. Estimating risk

for the individual women is difficult and most breast cancers are not

attributable to risk factors other than female gender and increased age.

One of the important breakthroughs that modern medicine has achieved is

to establish that Breast Cancer is Curable. The focus now is not only on ensuring

that kind of treatment that gives patients the best chance of survival, but also

on examining issues that impact quality of life for those who combat Breast

Cancer.

Breast Cancer Foundation – India is holding a national seminar on Breast

Cancer Management with a national perspective of developing a community

oriented breast cancer programme. This national perspective will call for two

sessions of intense deliberation and analysis of available breast cancer data

through breast cancer experts in India. You, a known and doyen in this field are

requested to grace this momentous meeting with your kind presence and to

make it more meaningful. The scientific programme is scheduled to be held on th th04 & 05 August, 2012 at Hotel Patliputra Ashoka, Patna.

We will highly appreciate your participation in this programme where many

issues related to the management of the disease will be addressed.

Dr. J. K. SinghOrg. Chairman

National Seminar of BCF-India & Director,

Mahavir Cancer Sansthan, Patna

Dr. Manisha SinghOrg. Secretary

National Seminar of BCF-India

HOD, Medical Oncology,

Mahavir Cancer Sansthan,Patna

Breast Cancer Foundation-IndiaPatna Museum

Yakshini

Set up in 1917, the Patna Museum is one

of the few grand museums in India, and is

committed to offering a scientific vision to

understand the evolution of history. As a

repository of ancient glory, Patna

Museum is, however, truly the cultural

pride of Bihar. This museum has the

privilege of preserving the holy relic

casket of Lord Buddha which contains his

ashes and other materials discovered

during the excavation of a stupa

belonging to sixth century BC at Vaishali. Among the stone sculptures, a special mention must be

made about the famous female figure of the Mauryan period, third century BC. Discovered at

Deedarganj (Patna), the magnificent statue is popularly known as Deedarganj Yakshi.

This is a fabulous female beauty in stone. The amazing beauty of this statue

has a captivating attraction to make anyone spellbound. The size yakshini

discovered by accident at deedarganj, Patna. The statue of Mauryan folk are

tradition represents. "The highest water mark of sculptural art in the

indigenous tradition. "In the right hand the female figure holds a "Chowar"

and the lower part of her body's richly covered with ornaments and folded

garments. Itis an example of the art of the transitional period between the

Maurya and sunga epochs.


Breast Cancer Foundation - IndiaCENTRAL OFFICE BEARERS

FOUNDER SECRETARY GENERAL

Dr. M. K. Mahajan, Ludhiana

PRESIDENT

Dr. Sanjay Sharma, Mumbai

VICE-PRESIDENT

Dr. S. Parmeshwaran, Trivendrum

NATIONAL SECRETARY

Dr. Jitendra Kumar Singh

TREASURER

Dr. S. Jhaver, Ludhiana

EDITOR

Dr. Manisha Singh, Patna

JOINT SECRETARY

Dr. Mohan Vamsy, Hyderabad Dr. N. Gopinath, Bangalore Dr. Preeti Jain, Patna

EXECUTIVE COMMITTEE

Dr. K. S. Panda, Cuttack Dr. G. S. Bhattacharyya, Kolkata Dr. K. Uma Devi, Bangalore

Dr. P. K. Sur, Kolkata Dr. Ramesh Bilimagga, Bangalore Dr. Anita Borges, Mumbai

Dr. Shyam Srivastava, Mumbai Dr. Deepak M. Parikh, Mumbai Dr. E. Hemant Raj, Chennai

Dr. M. K. Piya, Nepal Dr. Gurunath Kilara, Bangalore Dr. Raj Govind Sharma, Jaipur

SCIENTIFIC COMMITTEE

Dr. Rajan Badwe, Mumbai Dr. S. H. Advani, Mumbai Dr. G. K. Rath, Delhi

Dr. Hemant Malhotra, Jaipur Dr. P. M. Parikh, Mumbai Dr. H. M. Bathena, Mumbai

Dr. K. Bhattacharya, Kolkata

1


EXECUTIVE MEMBERS

Dr. B. B. Pandey

Dr. U. P. Singh

Dr. S. K. Sinha

Dr. Chandreswar Singh

Dr. A. Nath

Dr. P. C. Jha

Dr. Tanveer Majid

Dr. Preeti Jain

Dr. Rajeev Kumar

Dr. Ishoo Taneja

Dr. Vineeta Trivedi

Dr. Alok Kumar

ORGANIZING COMMITTEE

ORG. CHAIRMAN

Dr. J. K. SinghORG. SECRETARY

Dr. Manisha Singh

TREASURER

M. D. N. Singh

2

National Seminar-2012Patna

th th4 -5 Aug. 2012


16th – 2012 Kolkata

Highlights of the Previous Conferences

Fight against Breast Cancer - Journey forward

3


4


Clinical Trials

Dr. J. K. SinghPrincipal Investigator

Dr. Manisha SinghCo-Principal Investigator

5

Last three year, we have done fifteen breast cancer trials -

1. An open label study investigating long safety and tolerability of Nasalfent (fentanyl Citrate Nasal Spray) in the treatment of Breakthrough Cancer Pain (BTCP) in subjects taking Regular Opioid Therapy.

2. A Multicentre, Double- blind, double-blind, double-dummy, Two-phase crossover study of Nasalfent (Fentanyl Citrate Nasal Spray) compared to Immediate Release Morphine Sulphate Tablets in the Treatment of Breakthrough Cancer Pain (BTCP) in subjects taking regular Opioid Therapy.

3. A Randomized, open label, two- treatment, two-period, single dose, crossover, bioequivalence study of 2intravenous infusion of liposomal doxorubicin 50 mg/m , of sun pharmaceutical industries limited India and

2doxil 50 mg/m marketed by tibotec therapepeutics, A division of ortho biotech, USA in 12 patients with advanced breast cancer/ovarian cancer, under fed conditions.

4. Randomized, Phase III-b, Multi-center, Open-label, Parallel study of Enoxaparin (low molecular weight heparin) given concomitantly with chemotherapy vs chemotherapy alone in patients with inoperable gastric and gastro-oesophageal Cancer.

5. Randomized phase 3 Study of Pemetrexd in Combination with Cisplatin in Combination with Cisplatin Verses Cisplatin Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer.

6. A Phase IIb RCT of Neoadjuvant chemotherapy comparing Paclitaxel, ifosfamide and Cisplatin with Paclitaxel and 5-FU in Patients with Locally Advanced Head and Neck Cancer.

7. An Open Label, Balanced, Randomized, Two Period, Two Treatment, Two Sequence, and Two Way Crossover Study to Evaluate Safety and Pharmacokinetic Comparision of Intravenous Infusion of Paclitaxel Lipid Suspension and Taxol® in Patients with Metastatic Breast Cancer “357”.

8. A multicentre, randomized, open label, two-period, two-treatment, two-way crossover, bioequivalence study comparing Capecitabine tablets 500 mg (Manufactured by Intas Pharmaceuticals Ltd., India) to the reference listed drug XELODA® 500 mg tablets (Manufactured by Roche Pharma AG, Germany) in patients of Locally Advanced or Metastatic Breast Cancer or Metastatic Colorectal Cancer under fed condition.

9. A multicentre, randomized, open label, two-way crossover, bioequivalence Study comparing ® Capecitabine 3 x 500 mg (Intas Pharmaceutical Ltd) to the Reference listed XELODA 3 x500 mg in

patients with Patients of Metastatic Breast Cancer or Metastatic Colorectal cancer under fed condition “238”

10. A randomized, Controlled Phase III trial of Picoplatin and Best Supportive Care (BSC) versus BSC alone in Patients with Small Cell Lung Cancer (SCLC), Refractory or Progressive within Six Months of Completing First-Line, Platinim-Containing Chemotherapy-Poniard Protocol 0601.

11. “A phase II study of determine the safety, Efficacy, and Pharmacokinetics of Multiple Intravenous Dose of ALD518 80MG, 160mg Versus Placebo administered to Patients with Non-Small Cell Lungs Cancer – Related Fatigue and Cachexia.

12. A Randomised, Open-Label, Phase 2 Trial of drug With or Without drug in Patients with Previously Untreated Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer.

13. A multicentre, randomized, open label, two-period, two-treatment, two-way crossover, bioequivalence study comparing drug 500 mg in locally Advanced Breast Cancer or metastatic Breast cancer or Colorectal Cancer Patients under fed Condition.

14. A Randomised, Open-Label, Phase 2 Trial of drug With in Patients with Previously Untreated Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer.

15. Open-Label randomized, multidose, parallel study to evaluate efficacy and safety of iv nanosomal drug lipid suspension and drug.

Breast Cancer Foundation-IndiaCONFERENCE HIGHLIGHTS

Guest Lectures by National & International Faculty

Panel Discussions with Multidisciplinary approach

Screening and early detection program

Consensus meeting to form the guidelines related to screening and early detection of Breast Cancer Consensus meeting to form the guidelines related to screening and early detection of Lung Cancer Confirmed participation of 92 leading and renowned oncologists of the country

Almost all the directors of cancer centres and HOD's of various departments have confirmed their participation

Public Participation Program with Various NGO's

Meeting with Pharma Persons - on Economizing Cancer Care

INTERNATIONAL SPEAKER

DR. DAVID DALE, MD, USA is an oncologist and professor of medicine at the University of Washington (Seattle, Washington). Dr. Dale's career has included many honors, the most recent being his appointment as president of the American College of Physicians (ACP; Washington, DC). He has also served as dean of the University of Washington Medical School and was for many years president of Alpha, the national medical honor society. Among oncologists, Dr. Dale is perhaps best known for his work on granulocyte colony - stimulating factor (G-CSF) for the treatment of cyclic and congenital neutropenia.

6


NATIONAL SEMINAR BCF-INDIA

CONFIRM FACULTY

1 Dr. S. S. Nayyar — Sr. Consultant, Indian Institute of Oncology, Indore

2 Dr. P. M. Parikh — Convener, ICON& President, ISMPO (Mumbai)

3 Dr. Hemant Malhotra — Prof. & Head Dept of Med. Oncology, SMS Hosp, Jaipur and Secretary, ISMPO

4 Dr. Rajendra Toprani — Director, HCG Cancer Centre, Ahmedabad

5 Dr. T. Raja — Sr. Consultant, Dept. of Medical Oncology, Apollo, Chennai

6 Dr. A. K. Anand — HOD, Dept of Radiotherapy, Fortis Hospital, Delhi

7 Dr. G. K. Rath — Director, IRCH, AIIMS, Delhi

8 Dr. Raman Deshpande — HOD, Thoracic Oncology, Asian Institute of Oncology, Mumbai

9 Dr. U.P. Shahi — HOD, Radiotherapy Dept., BHU, Varanasi

10 Dr. Sangeeta Desai — HOD, Basic Science, TMH, Mumbai

11 Dr. M. C. Kar — HOD, Medical Oncology, Apollo Cancer Hospital, Kolkata

12 Dr. P. S. Sridhar — Consultant, HCG Cancer Center, Bangalore

13 Dr. Tanweer Shahid — Consultant, Tata Memorial Centre, Kolkata

14 Dr. Chirag Desai — Sr. Consultant & Medical Oncologist, Ahmedabad

15 Dr. SD Sharma — Scientific Officer, BARC, Mumbai

16 Dr. Tapti Sen — Consultant Oncology, Kolkata

17 Dr. M. S. Vidyasagar — HOD, Radiotherapy Dept., Manipal

18 Dr. Ashish Goel — Surgical Oncologist, RGCI, Delhi

19 Dr. M. K. Mahajan — HOD, Dept. of Radiotherapy, CMC, Ludhiana

20 Dr. Shibashish Bhattacharya — Medical Oncologist, Kolkata

21 Dr. Kaustav Talpatra — HOD, Radiotherapy Dept., Dhirubhai Ambani Hospital, Mumbai

22 Dr. Sanjay Sharma — Chief, Surgical Oncology, Asian Institute of Oncology, Mumbai

23 Dr. K. S. Panda — Director, Panda Cancer Institute, Cuttack

24 Dr. Harit Chaturvedi — Director, Max Hospital, Saket, Delhi

7


8

25 Dr. Sapna Nagia — HOD, Radiotherapy Dept., Apollo Cancer Hospital, Delhi

26 Dr. G. S. Bhattacharya — HOD, Medical Oncology, AMRI, Kolkata

27 Dr. A. A. Ranade — Director, Pune Cancer Hospital, Pune

28 Dr. Amarnath Gopalraj — HOD, Radiotherapy-Cancer Centre, Madurai

29 Dr. D. M. Parikh — HOD, H&N Oncology Dept., Asian Cancer Institute, Mumbai

30 Dr. Ramesh Bilimagga — Director, Bangalore Institute of Oncology, Bangalore

31 Dr. Vijay A. Reddy — Director, Apollo Cancer Institute, Hyderabad

32 Dr. Chanchal Goswami — Director, B. P. Poddar Cancer Hospital, Kolkata

33 Dr. S. Hukku — President, AROI, Delhi

34 Dr. D. N. Savant — Head, Reconstructive Surgery, Asian Institute of Oncology, Mumbai

35 Dr. Sanjeev Mishra — Director, AIIMS, Jodhpur

36 Dr. S. N. Senapati — HOD, Radiotherapy, Regional Cancer Centre, Cuttack

37 Dr. S. K. Verma — HOD, Radiotherapy, Bokaro

38 Dr. Ravi Deo — Chief, Surgical Oncology, Manipal Cancer Institute, Bangalore

39 Dr. Subramania Iyer — HOD, Head & Neck Oncology, Maa Amrita Cancer Institute, Kochi

40 Dr. Amar Verma — HOD, Dept. of Paediatric, RIIMS, Ranchi

41 Dr. D. P. Singh — HOD, Radiotherapy, SMS Medical College, Jaipur

42 Dr. S. Parmeshwaran — HOD, Radiotherapy, Regional Cancer Centre, Trivandrum

43 Dr. O. P. Singh — HOD, Radiotherapy, Bhopal Medical College, Bhopal

44 Dr. Rajesh N. Sharan — Dept. of Biochemistry, North East Hill University, Shilong- 793022

45 Dr. Shyam Aggarwal — HOD, Medical Oncology, Ganga Ram Hospital, Delhi

46 Dr. Mandar Nadkarni — HOD, Dept. of Surgery, Dhirubhai Ambani Hospital, Mumbai

47 Dr. Suma Chakarbarthi — HOD, Radiology, Apollo Hospital, Kolkata

48 Dr. Rajesh Jindel — Sr. Consultant, Medical Oncology, Kolkata

49 Dr. Asis Mukherjee — Director, Cancer Centre, Kolkata

50 Dr. Tanveer Abdul Mazeed — Sr. Consultant, Surgical Oncology, Mumbai


9

51 Dr. B. R. Srivastava — Director, Cancer Institute, Gwalior

52 Dr. Shekhar Salkar — HOD, Dept. of Surgical Oncology, Goa Medical College, Goa

53 Dr. Vinay Deshmane — Head, Reconstructive Surgery, Asian Institute of Oncology, Mumbai

54 Dr. Jaydeep Biswas — Director, Chittranjan Cancer Institute, Kolkata

55 Dr. C. S. Madhu — Director, Kottayam Cancer Centre, Kerala

56 Dr. R. K. Vyas — HOD, Dept. Radiotherapy, GCRI, Ahmedabad

57 Dr. Deeptirani Samanta — Head, Dept. of Medical Oncology, Regional Cancer Centre, Cuttack

58 Dr. Awadhesh Kr. Pandey, — HOD, Radiation Oncology, Govt. Medical College & Hospital, Chandigarh

59 Dr. S. B. L. Srivastava — Medical Director, Birla Institute of Medial Sciences, Gwalior

60 Dr. M. L. Bhatt — HOD, Dept. or Radiotherapy, King George Medical College, Luckhnow

61 Dr. Digpal Dharkar — Director, Indore Cancer Foundation, Indore

62 Dr. T. P. Sahoo — Director, Cancer and Haematology Chirayu Medical College and Hospital, Bhopal

63 Dr. Mohan Vamsy — Director, Omega Hospital, Hyderabad

64 Dr. Pankaj Shah — Director, GCS Medical College, Ahmedabad

65 Dr. Deepak Dbkara — Sr. Consultant, Tata Memorial Centre, Kolkata

66 Dr. Amit Dutt Dwary — Sr. Consultant, Tata Memorial Centre, Kolkata

67 Dr. Indranil Ghosh — Sr. Consultant, Tata Memorial Centre, Kolkata

68 Dr. Santanu Pal — Sr. Radiation Oncologist, Kolkata

69 Dr. A. Nath — HOD, R&D, Mahavir Cancer Institute & Research Centre, Patna

70 Dr. N. K. Kalita — HOD, Dept. of Radiotherapy, Regional Cancer Centre, Guwahati

71 Dr. Thangarajan Rajkumar — Prof. & HOD, Molecular Oncology Adyar Cancer Institute, Adyar Chennai

72 Dr. E. Hemanth Raj — Medical Director, Apollo Hospital, Chennai


10

COMMITTEE TO FORM CONSENSUS GUIDELINE ON SCREENING AND EARLY DETECTION OF LUNG CANCER - INDIAN PERSPECTIVE

1. Sri Vyas Jee — I.A.S., Patna

2. Dr. P. M. Parikh — Convenor,ICON& President, ISMPO (Mumbai)

3. Dr. B. R. Srivastava — Director, Cancer Institute, Gwalior

4. Dr. E. Hemanth Raj — Medical Director, Apollo Hospital, Chennai

5. Dr. G. S. Bhattacharyya — HOD, Medical Oncology, AMRI, Kolkata

6. Dr. Vijay Anand Reddy — Director, Apollo Cancer Institute, Hyderabad

7. Dr. Jaydip Biswas — Director,Chittranjan Cancer Institute, Kolkata

8. Dr. K. S. Panda — Director, Panda Cancer Institute, Cuttack

9. Dr. Digpal Dharkar — Director, Indore Cancer Foundation, Indore

10. Dr. S.B.L. Shrivastava — Medical Director, Birla Institute of Medial Sciences, Gwalior

11. Dr. Pankaj Shah — Director, GCS Medical College, Ahmedabad

12. Dr. Ramesh Bilimagga — Director, Bangalore Institute of Oncology, Bangalore

13. Dr. G. K. Rath — Director, IRCH, AIIMS, Delhi

14. Dr. T. P. Sahoo — Director, Cancer and Haematology, Chirayu Medical College and Hospital, Bhopal

15. Dr Ashok Kumar — Dy. Director, Tuberculosis Cell, Delhi

16. Dr. Sanjay Sharma — Sr. Consultant, Surgery Dept. Asian Institute of Oncology, Mumbai

17. Dr. Raman Deshpande — Sr. Consultant, Surgery Dept. Asian Institute of Oncology, Mumbai

18. Dr. J. K. Singh — Director, Mahavir Cancer Sansthan, Patna

Programme Co-ordinator — Dr. Manisha Singh, Patna


11

COMMITTEE PUBLIC PARTICIPATION PROGRAMME WITH VARIOUS NGO'S

1. Dr. S. S. Nayyar, Sr. Consultant,

Indian Institute of Oncology, Indore

2. Dr. M. K. Mahajan — HOD, Dept. of Radiotherapy,

CMC, Ludhiana

3. Dr. Ravi Deo — Chief, Surgical Oncology,

Manipal Cancer Institute, Bangalore

4. Dr. G. S. Bhattacharya — HOD, Medical Oncology,

AMRI, Kolkata

5. Dr. Manju Geeta Mishra — Chairman Scientific Committee, FOGSI, Patna

6. Dr. Pramila Modi — Ret. Prof. of NMCH, Patna

7. Dr. Anita Singh — President BOGS, Patna

8. Dr. Sushma Pandey — HOD, Gynaecology Dept., PMCH, Patna

9. Shilpee Bhattacharya — Club Friday, Kolkata

10. Nupur Banarjee — Club Friday, Kolkata

11. Shukla Kundu — Club Friday, Kolkata

12. M. Roy Chowdhary — Club Friday, Kolkata

13. Dr. J. K. Singh — Director,


Programme Co-ordinator — Dr. Vineeta Trivedi, Patna

—


12

MEETING WITH PHARMA PERSON ON MINIMIZING THE COST OF MEDICINE FOR CANCER PATIENTS

1. Dr. P. M. Parikh — Convener,

ICON& President, ISMPO (Mumbai)

2. Dr. G. S. Bhattacharyya — HOD, Medical Oncology,

AMRI, Kolkata

3. Dr. Hemant Malhotra — Prof. & HOD, Medical Oncology,

SMS Hospital, Jaipur and Secretary, ISMPO

4. Dr. Pankaj Shah — Director, GCS Medical College, Ahmedabad

5. Dr. Jaydip Biswas — Director, Chittranjan Cancer Institute, Kolkata

6. Dr. G. K. Rath — Director, IRCH, AIIMS, Delhi

7. Dr. T. P. Sahoo — Director, Cancer and Haematology Chirayu

Medical College and Hospital, Bhopal

8. Dr. S. S. Nayyar, — Sr. Consultant,

Indian Institute of Oncology, Indore

9. Dr. Digpal Dharkar — Director, Indore Cancer Foundation, Indore

10. Dr. B. R. Srivastava — Director,

Cancer Institute, Gwalior

11. Dr. Ramesh Bilimagga — Director,

Bangalore Institute of Oncology, Bangalore

12. Dr. K. S. Panda — Director, Panda Cancer Institute, Cuttack

13. Dr. S.B.L. Shrivastava — Medical Director, Birla Institute of Medial Sciences, Gwalior

14. Dr. J. K. Singh — Director,


Programme Co-ordinator — Dr. Preeti Jain, Patna


13

NATIONAL SEMINAR OF BREAST CANCER FOUNDATION- INDIA, PATNASCIENTIFIC PROGRAM

DAY – I 04/08/2012

Chairperson

08.00-08.30 AM REGISTRATION

08.30-08.40 AM Welcome & Introduction Dr. J. K. Singh

SESSION – I

08.40-09.00 AM

New Horizon in Breast Cancer Genomics

–

Dr. Amar Verma, Ranchi

Dr. U.P. Shahi, Varanasi

Dr. M. S. Vidyasagar, Mangalore

Dr. Usha Singh, Patna

09.00-09.20 AM

Changes in Gene Expression due to accumulation of Pesticides and arsenic in Breast Cancer Patient

- Dr. A. Nath, Patna

09.20-09.40 AM

Dr. Suma Chakraborty, Kolkata

SESSION –

II

09.40-10.00 AM

Novel Biomarkers of cancer for clinical applications-

Dr. Rajesh Sharan, Shilong

Dr. Amarnath Gopalraj, Madurai

Dr. Akhileswar Pd. Sinha, Patna10.00-10.20 AM

Prognostic and Predictive Markers –

Reporting Guidelines

– Dr. Sangeeta Desai , Mumbai

SESSION –

III

10.20-11.00 AM

Panel Discussion on

Benign Breast Diseases –

Its Treatment guidelines

Moderator :

Dr. Mohana Vamsy, Hyderabad

Panelists :

Dr. Suma Chakraborty, Kolkata

Dr. Ashish Goel, Delhi

Dr. Tanveer Majid, Mumbai Dr. Sangeeta Desai, Mumbai Dr. A. A. Hai, PatnaDr. Harit Chaturvedi

Dr. U. P. Singh, Patna

Dr. C. Khandelwal, Patna

Dr. B. B. Pandey, Patna

11.00-11.20 AM

TEA BREAK

SESSION –

IV

11.20-11.40 AM

Neo Adjuvant Therapy in Breast Cancer : Promise and Peril

–

Dr. Hemant Malhotra, Jaipur

Dr. G. S. Bhattacharya, Kolkata

Dr. D. P. Singh, Jaipur

Dr. Anita Singh, Patna

11.40-12.00 Noon

Long terms adverse effect of systemic therapy

– Dr. Dinesh Pendarkar, Mumbai

SESSION –

V

12.00-12.20 AM

Dilemmas in Chemotherapy in Metastatic Breast Cancer –

An over view –

Dr. T. P. Sahoo, Bhopal

Dr. Santanu Pal, Kolkata

Dr. Tanweer Shahid, Kolkata

12.20-01.00 PM

Multidisciplinary Tumor Board : Case capsule on Medical Oncology

Moderator : Dr. Chirag Desai, Ahmedabad

Panelists –

Dr. Hemant Malhotra, JaipurDr. Dinesh Pendarkar, MumbaiDr. Tapti Sen, KolkataDr. Manisha Singh, PatnaDr. Deepti Rani Samanta, Cuttack

01.00-02.00PM LUNCH


14

SESSION - VI

02.00-02.20 PM Conservative Breast Surgery – its relevance in Indian patientsDr. Mandar Nadkarni, Mumbai

Dr. K. S. Panda, Cuttack

Dr. S. K. Verma, Bokaro

02.20-02.40 PM Optimizing Reconstructive outcomes when post Mastectomy Radiotherapy is necessary –

Dr. Vinay Deshmane,

Mumbai

SESSION –

VII

02.40-03.00 PM

Is sentinel Lymph Node Biopsy Ready for Prime time in India

– Dr. Sanjay Sharma, Mumbai

Dr. Ravi Deo, Bangalore

Dr. D. K. Parida, Shilong03.00-03.20 PM

Future of Breast Cancer Surgery –

Dr. Raman Deshpande, Mumbai

SESSION –

VIII

03.20-03.40 PM Economizing cost of Cancer in India–

Dr. Digpal Dharkar, Indore

Dr. S. Iyer, Kochi

Dr. R. Toprani, Ahmedabad

Dr. Sudhakar Singh, Patna

03.40-04.10 PM

Case Capsule on Surgical Oncology –

Moderator –

Dr. Sanjeev Mishra, Lucknow

Panelists -



Dr. Vinay Deshmane, Mumbai


Dr. S. Parmeshwaran, Trivandrum


04.10-04.30 PM TEA BREAK

SESSION – IX

04.30-04.50 PM

Isotope and Breast Cancer –

Dr. B. Krishna, Mumbai

Dr. S. S. Nayyar, Indore

Dr. Suma Chakrabarthy, Kolkata

04.50-05.10 PM

Treatment Strategies for Triple negative Breast Cancer

–

Dr. Rakesh Chopra, New Delhi

SESSION -

X

05.10-05.30 PM

Endocrine Therapy in Breast Cancer –

Dr. Chanchal Goswami, Kolkata

Dr. M. C. Kar, Kolkata

Dr. P. N. Pandit, Patna05.30-05.50 PM

Role of Nab Paclitaxol in MBC –

Dr. G. S. Bhattacharya, Kolkata

06.00-07.00 PM

INAUGURAL PROGRAMME

07.00-07.30 PM

TEA BREAK

SESSION –

XI

07.30-08.30 PM

Holistic Management of Febrile Neutropenia (Web Cast) –

Dr. David Dale, USA

Panel Discussion on

Febrile Neutropenia –

Indian Perspective

Moderator –

Dr. P. M. Parikh, Mumbai

Panelists –

Dr. Chanchal Goswami, KolkataDr. Manisha Singh, PatnaDr. M. C. Kar, KolkataDr. Hemant Malhotra, JaipurDr. Dinesh Pendharkar, Mumbai

Dr. Pankaj Shah, Ahmedabad

Dr. Jaydeep Biswas, Kolkata

Dr. Anita Singh, Patna

08.30 PM Onwards DINNER at Hotel Patliputra Ashok


15

National Seminar of Breast Cancer Foundation– India, PatnaScientific Program

DAY – II 05/08/2012

Physicians

Dr. Dilip Singh - Bhagalpur

Dr. D.K. Srivastava - Patna

Dr. T.R.V.P.N. Singh - Patna

Dr. Gopal Pd. Sinha - Patna

Dr. Sudhir Kr. - Patna

Dr. Rajiv Ranjan - Patna

Dr. Ajit Kr. Mishra - Patna

Radiologists

Dr. S.M. Das

Dr. Sumo Chakarborty

SESSION – XII

08.30-10.00 AM

Committee to form consensus guideline on screening and early detection of Lung Cancer –

Indian Perspective

Sri Vyas Jee, I.A.S., Patna

Dr. P. M.

Parikh, Mumbai

Dr. B. R.

Srivastava, Gwalior

Dr. E. Hemanth Raj, Chennai

Dr. G. S.

Bhattacharyya, KolkataDr. Pankaj Shah, Ahmedabad

Dr. Vijay Anand Reddy, HyderabadDr. Jaydeep Biswas, Kolkata

Dr. K. S.

Panda, Cuttack




Dr. G. K.

Rath, Delhi

Dr. Ramesh Bilimagga, Bangalore


Dr. J. K. Singh, Patna (Convener)

DAY – II

05/08/2012

Chairperson

SESSION – XIII

09.00-09.20 AM

Psycho Social Issues in Breast Cancer Patients

–

Dr. Harit Chaturvedi, Delhi

Dr. S. Hukku, Delhi

Dr. S. D. Sharma, Mumbai

09.20-09.40 AM

Management of Breast Cancer in Elderly Patients -

Dr. Deepak Parikh, Mumbai

SESSION –

XIV

09.40-10.00 AM

New Agents to overcome endocrine resistance

–

Dr. M. C. Kar, Kolkata

Dr. Shekhar Salkar, Goa

Dr. Rajesh Jindel, Kolkata

10.00-10.20 AM

mTOR inhibitors in Metastatic Breast Cancer

–

Dr. Shyam Aggarwal, Delhi

SESSION –

XV

10.20-10.40 AM

Interpreting and applying Clinical Trials in Breast Cancer in India

–

Dr. P. M. Parikh, Mumbai


Dr. B. R. Srivastava, Gwalior

Dr. Shibashish Bhattacharya, Kolkata

10.40-11.00 AM Hereditary Breast Cancers in India– Dr. T. Rajkumar, Chennai

11.00-11.20 PM Breast Cancer Screening International Perspective and What is best for India– Dr. G. K. Rath, Delhi

11.20-11.40 AM TEA BREAK


16

SESSION – XVI

11.40-12.10 PM Partial Breast irradiation in Indiancontext –Dr. Sapna Nagia, Delhi

Dr. I. B. Sinha, Patna

Dr. A. K. Pandey, Chandigarh

Dr. Mithlesh Kumar, Patna

12.10-12.30 PM Radiation after Neo Adjuvant Chemotherapy –

Dr. A. K. Anand, New Delhi

12.30-12.50 PM Post Mastectomy Radiotherapy

Newer Techniques & Future Directions

–


SESSION -

XVII

12.50-01.30 PM Panel Discussion

Case Capsule on Radiation Oncology-

Moderator –

Dr. Vijay Anand Reddy, Hyderabad

Panelists –

Dr. A. K. Anand, Delhi

Dr. Uday P. Shahi, Varanasi

Dr. Vidya Sagar, Mangalore

Dr. Kaustav Talpatra, Mumbai

Dr. O. P. Singh, Bhopal


Dr. G. K.

Rath, Delhi

Dr. Rajesh Singh, Patna

01.30-02.30 PM

LUNCH

02.30- 03.00 PM Meeting with Pharma Person on Minimizing the Cost of Medicine for Cancer Patients Dr. P. M. Parikh, Mumbai

Dr. B. R. Srivastava, Gwalior

Dr. E. Hemanth Raj, Chennai

Dr. G. S. Bhattacharyya, Kolkata

Dr. Pankaj Shah, Ahmedabad

Dr. Vijay Anand Reddy, Hyderabad

Dr. Jaydeep Biswas, Kolkata



Dr. G. K. Rath, Delhi



Dr. J. K. Singh, Patna (Convener)

03.00-04.00 PM Committee

Public Participation Programme with Various NGO’s


Dr. S. S. Nayyar, Indore

Dr. Ravi Deo, Bangalore

Dr. G. S. Bhattacharyya, Kolkata

Dr. Shilpee Bhattacharya, Kolkata

Dr. Manju Geeta Mishra, Patna

Dr. Pramila Modi, PatnaDr. Anita Singh, PatnaDr. Sushma Pandey, PatnaDr. J. K. Singh, Patna (Convener)

Ashoka Hall –

A

Ground Floor

04.00 PM VALEDICTORY Dr. J. K. Singh, Patna


17


18


19

1. Name : _____________ _______________ ______________

Surname First Name Middle Name

2. Date of Birth :

DD MM YY

3. Gender : Male Female

4. Nationality :

5. Mailing Address :

City ________________ State_________________ Country_______________

Pin/Zip ___________ Tel. (with STD Code)____________ Fax. _____________

Email___________________________ Mob. No.__________________________

6. Professional Qualifications : _____________________Name of the medical College / University

Year obtained ____________ Registration No. ______________Registered MCI/DCI______________

7. Current Designation : ________________ Name of Organization/Hospital: _________________

8. Special area of interest : ___________________________________________________________

9. Experiences : ____________________________________________________________________

Any other relevant significant achievement

Amount of oncology work : 10-20% 20-40% 50-60% 100%

Date : ___________________ Signature

DD. or Cheque for Rs. 2000/- Should be drawn in favour of "Breast Cancer Foundation - India" payable at Patna or Ludhiana. To add Rs. 70/- for outstation cheques. (Kindly send through Registered post or Courier only)

Address: (1) Dr. Jitendra Kumar Singh (2) Dr. M.K. Mahajan

National Secretary, BCFI & The Secretary General

Director, Mahavir Cancer Sansthan, Breast Cancer Foundation - India

Phulwari Sharif, Patna - 801 505 12 - E Tagore Nagar,

Ph. : 0612 - 2250127, 2253956, Ludhiana - 141 001

Fax : 0612 2253957 Punjab (India)Email : [email protected] / [email protected]

Office Use Membership No. _______________ Approval : Yes / NoFull Asossiate ___________________

Dr. J. K. Singh

(Membership Application Form)


20

Contact Us

DR. J. K. SINGHOrg. Chairperson, National Seminar of BCF - India

Hon. National Secretary, Breast Cancer Foundation - India

Director, Mahavir Cancer Sansthan, Patna

BIHAR & JHARKHAND CHAPTER OFFICE ADDRESS

Block-2, Flat No. JF/10, Arya Kumar Road, Rajendra Nagar, Patna - 800 016

Mobile : 094310 21001 / 08877999919 Fax No. : 0612 - 2253957

E-mail : [email protected] / [email protected]

Event Manager for National Seminar of BCF-India

MR. RAJESH SHARMA

MEDCON INTERNATIONALE Mob. : 93740-73512

Email ID : [email protected] / [email protected]

pawapuri theme-beyond the horizon - bcf india cancer foundation-india breast cancer foundation -...

Documents